Documents FDA Guidance_Disclosing Risk_Generic

1. FDA DRAFT GUIDANCE FOR INDUSTRY REVISED Stuart E Coleman Promotional Review and Regulatory March 30th, 2015 1 2. Brief Summary and Adequate Directions for Use: Disclosing…

Documents FDA Update on Advertising and Promotion of Prescription Drugs

FDA Update on Advertising and Promotion of Prescription Drugs Thomas Abrams, R.Ph., M.B.A. Division of Drug Marketing, Advertising, and Communications Food and Drug Administration…

Documents Speakers: Julie Chronis, Regulatory Counsel, Office of Prescription Drug Promotion, Center for Drug....

Speakers: Julie Chronis, Regulatory Counsel, Office of Prescription Drug Promotion, Center for Drug Evaluation and Research, Office of Medical Products and Tobacco, FDA Roberta…

Documents OPDP Update on Oversight of Prescription Drug Promotion Thomas Abrams Director Office of...

Slide 1 OPDP Update on Oversight of Prescription Drug Promotion Thomas Abrams Director Office of Prescription Drug Promotion Food and Drug Administration September 16, 2013…